Counter drone company surges past $1 billion valuation with new contract win

This company's shares are sharply higher after it announced a lucrative contract with a South Korean customer.

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Key points
  • Electro Optic Systems has signed a lucrative contract with a South Korean customer.
  • The company will also set up a joint venture to drive future sales.
  • EOS shares are trading significantly higher on the news.

Shares in Electro Optic Systems Ltd (ASX: EOS) jumped more than 18% on Monday after the company said it had signed a contract to supply a high energy laser weapon to a South Korean customer.

The company said in a statement to the ASX that it had signed a binding conditional contract worth about $120 million to manufacture and supply a 100kW "high energy laser weapon" to a company in the Republic of Korea.

It would also establish a joint venture between itself and the customer to supply the weapons within South Korea, and would license the intellectual property around the weapon to the new joint venture company.

The product will be manufactured at the company's new laser weapon manufacturing facility in Singapore, the company said.

A silhouette of a soldier flying a drone at sunset.

Image source: Getty Images

Milestone payments to come

While the total amount payable was US$80 million, the company would also receive an initial deposit under the agreement.

The company went on to say:

The conditions of the contract include the payment by the customer of the initial deposit (US$18 million), the customer procuring the issuance of a letter of credit for the remaining amount of the contract, and the customer inspecting and being satisfied with EOS' Singapore facility. The customer expects these to be completed prior to 31 January 2026.

The contract was also subject to customary terms, including milestone payments and full refund entitlements in the event of non-performance, EOS said.

EOS said it expected that the contract would be fulfilled by the end of 2027.

Contract follows year of testing

The company said the laser weapon was part of its technology suite, which included "using kinetic weapons, interceptors, rockets and high energy laser weapons to defeat drones''.

The EOS laser weapon development program included three years of field testing and numerous firing trials of the laser in close collaboration with customers. To ensure high performance, it is supplied with algorithms, radar, threat detection, target acquisition and beam locking systems. This conditional contract represents EOS' second export order for a 100kW class laser defence system and follows a first export order to a Western European customer, announced on 5 August 2025.

The company said it would also be holding a webinar on Tuesday, 16 December, during which Managing Director Dr Anreas Schwer would discuss the new contract.

Electro Optic Systems was valued at $966.7 million at the close of trade on Friday.

The company shares traded as high as $5.96, up 18.9% on Monday morning before settling back to be 15.5% higher at $5.79.

Bell Potter has a buy rating and $8.10 price target on its shares. 

Motley Fool contributor Cameron England has positions in Electro Optic Systems. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended Electro Optic Systems. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Technology Shares

Happy investor on tablet with finance graphs rising in overlay.
Technology Shares

WiseTech shares are taking off: Is this the start of a major comeback?

Strong FY26 results could trigger a major WiseTech valuation rethink.

Read more »

A couple sit in front of a laptop reading ASX shares news articles and learning about ASX 200 bargain buys
Earnings Results

FINEOS swings to profit in 1H26

FINEOS posted higher revenue, swung to profit, and outlined growth plans.

Read more »

Two IT professionals walk along a wall of mainframes in a data centre discussing various things
Technology Shares

Megaport shares are up more than 100% in 3 months. Are they still a buy?

Can the AI hype drive this stock even higher?

Read more »

A graphic showing a businessman running up a white upwards rising arrow symbolising the soaring Magellan share price today
Broker Notes

Up 250%! Broker tips this dividend paying ASX All Ords tech stock for more outsized gains

A top broker forecasts more outperformance from this dividend paying ASX tech stock.

Read more »

A man in his 30s holds his laptop and operates it with his other hand as he has a look of pleasant surprise on his face as though he is learning something new or finding hidden value in something on the screen.
Technology Shares

Bravura Solutions FY26 earnings: Revenue, profit, and dividends climb

Bravura Solutions surged 13% yesterday after releasing the result.

Read more »

A line up of job interview candidates sit in chairs against a wall clutching CVs on paper in an office setting.
Technology Shares

Seek shares plunge 14% despite solid results: Did investors overreact?

The market may be pricing in slower growth, weaker guidance and long-term AI disruption.

Read more »

Man analysing data on his laptop.
Technology Shares

Why this could be the best ASX tech stock to buy and hold

Xero already has almost five million customers, but I think there is still plenty of room for the business to…

Read more »

Businesswoman with a pleased smile reading on her laptop at a desk in the office with a look of satisfaction.
Technology Shares

Pro Medicus lands $23m St. Luke's Health System imaging contract

St. Luke’s Health System is Idaho’s largest private employer and not-for-profit healthcare provider.

Read more »